These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4194313)

  • 21. Prevention of maternal Rh sensitization: anti-Rh immune globulin.
    Wilson WB
    J Miss State Med Assoc; 1970 Feb; 11(2):53-6. PubMed ID: 4189158
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum prophylaxis of Rh isoimmunization. Findings in 70 cases].
    Dambrosio F; Clerici-Bagozzi D; Meroni P; Della Torre L
    Minerva Ginecol; 1970 Feb; 22(3):220-3. PubMed ID: 4192426
    [No Abstract]   [Full Text] [Related]  

  • 23. [Critical study of the results of an application of preventive treatment taking into account the systematic evaluation of feto-maternal hemorrhage].
    Huchet J; Crégut R; Briffoteaux P; Pinon F
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):203-5. PubMed ID: 4143442
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunoprophylaxis of neonatal hemolytic disease caused by Rh incompatibility. Analysis of a 5-year experience].
    Sansone G; Veneziano G; Mantegazza F; Cominetti M
    Pathologica; 1974; 66(961-962):477-89. PubMed ID: 4141760
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 26. The importance of antibody concentration, binding constant, and antibody heterogeneity in the suppression of immunity to the Rh factor.
    Pollack W
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):415-21. PubMed ID: 4110458
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trial of one millilitre injections of RH0 (D) immune globulin (human) in the prevention of Rh immunization: preliminary report.
    Bishop GJ; Krieger VI; Tait M; Walsh C
    Med J Aust; 1968 Jun; 1(26):1122-7. PubMed ID: 4174415
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention with gamma globulin of Rh isoimmunization: current problems. Review].
    Spensieri S; Carnevale-Arella E
    Riv Ostet Ginecol; 1968 Nov; 23(11):792-800. PubMed ID: 4187892
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect in vivo of anti-D gamma globulin on Rh-positive fetal erythrocytes].
    Massi GB; Curiel P; Cattaneo A; Cesa F
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1884-7. PubMed ID: 4186557
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunological prevention of iso-sensitization to Rh factor. Case studies].
    Nappi R; Scoppetta V; Menini C; Perri G
    Riv Emoter Immunoematol; 1974; 21(1-2):1-10. PubMed ID: 4138902
    [No Abstract]   [Full Text] [Related]  

  • 32. [The blood transfusion system today and in the future].
    Sachs V
    Munch Med Wochenschr; 1968 Jan; 110(4):218-24. PubMed ID: 4969458
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the effectiveness of anti Rh gamma globulin].
    García Roel R; Santos Martínez A; Salgado Alcocer N
    Ginecol Obstet Mex; 1974 Jan; 35(207):67-73. PubMed ID: 4133289
    [No Abstract]   [Full Text] [Related]  

  • 34. [New information about the prevention of Rh isoimmunization].
    Tesauro G
    Minerva Ginecol; 1968 May; 20(10):847-50. PubMed ID: 4186920
    [No Abstract]   [Full Text] [Related]  

  • 35. Component therapy.
    Schmidt PJ
    Int Anesthesiol Clin; 1982; 20(4):23-43. PubMed ID: 6816740
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of fetal Rh erythroblastosis].
    Benoit P
    Union Med Can; 1969 May; 98(5):753-6. PubMed ID: 4097154
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of rhesus haemolytic disease.
    Lancet; 1967 May; 1(7497):993-4. PubMed ID: 4164617
    [No Abstract]   [Full Text] [Related]  

  • 38. A blood transfusion hazard.
    Dickson DN; Wilkinson R
    S Afr Med J; 1977 Oct; 52(15):592. PubMed ID: 411185
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention of feto-maternal isoimmunizations. Organization in the Marseilles region].
    Nublat M; Dufour Y; Gaujoux J; Alcaraz J; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):209-11. PubMed ID: 4143444
    [No Abstract]   [Full Text] [Related]  

  • 40. Transplacental fetal-maternal hemorrhage: a review.
    Skaggs R
    J Am Osteopath Assoc; 1976 Mar; 75(7):658-65. PubMed ID: 56347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.